Sun Pharmaceutical Industries Limited has informed the Exchange about Credit Rating
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CRISIL Ratings has reaffirmed Sun Pharma's long-term bank facilities rating at 'Crisil AAA' and short-term facilities/commercial paper at 'Crisil A1+'. However, CRISIL has placed the AAA rating on 'Rating Watch with Developing Implications' following Sun Pharma's announcement of signing a definitive agreement to acquire Organon & Co. ICRA Limited also reaffirmed the ratings at '[ICRA]AAA(Stable)' and '[ICRA]A1+'. CRISIL will remove the rating from watch after a comprehensive assessment of the acquisition.
The reaffirmation at the highest investment grade indicates strong creditworthiness. The 'developing' watch signals uncertainty tied to the acquisition rather than credit deterioration, with the final rating to be determined post-assessment.